Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pat Price

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
The Role of the Global Coalition for Radiotherapy in Political Advocacy for Radiation Therapy as a Cost-Effective and Underfunded Modality Around the WorldPat Price, Birgit Fleurent, Shandi E Barney
Discovery Medicine|August 14, 2010
Positron emission tomography (PET) and anticancer drug developmentCatharine M L West, Terry Jones, Pat Price
Nature Reviews. Cancer|June 2, 2004
The potential of positron-emission tomography to study anticancer-drug resistanceCatharine M L West, Terry Jones, Pat Price
International Journal of Radiation Oncology, Biology, Physics|September 8, 2025
Radiotherapy Deserves the Spotlight: The First World Radiotherapy Awareness DayPat Price, Sandra Lynne Turner, Katie Wakeham, et al.
BJU International|November 6, 2010
Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy: an increasing but under-recognised problemRuth Langley, Pat Price, Philip Pollock, et al.
The Lancet. Oncology|December 17, 2022
UK cancer care: a watershed moment and the need for urgent interventionPat Price, Richard Sullivan, Amar Ahmed, et al.
Biochimica Et Biophysica Acta|December 14, 2004
Measuring tumor pharmacodynamic response using PET proliferation probes: the case for 2-[(11)C]-thymidinePaula Wells, Catharine West, Terry Jones, et al.
The Lancet. Oncology|May 31, 2026
The UK's radiotherapy workforce shortage: a case for reformHoria Vulpe, Alison Tree, Pat Price, et al.
The Lancet. Oncology|August 23, 2024
The UK needs to be a leader, not a lagger, in the global cancer effortMark Lawler, Ajay Aggarwal, Julie Gralow, et al.
The Lancet. Oncology|November 9, 2025
A deliverable national cancer control plan for the UK: lessons from abroad and the need for discipline at homeMark Lawler, Cary Adams, Eduardo Pisani, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
The Role of the Global Coalition for Radiotherapy in Political Advocacy for Radiation Therapy as a Cost-Effective and Underfunded Modality Around the WorldPat Price, Birgit Fleurent, Shandi E Barney
Discovery Medicine|August 14, 2010
Positron emission tomography (PET) and anticancer drug developmentCatharine M L West, Terry Jones, Pat Price
Nature Reviews. Cancer|June 2, 2004
The potential of positron-emission tomography to study anticancer-drug resistanceCatharine M L West, Terry Jones, Pat Price
International Journal of Radiation Oncology, Biology, Physics|September 8, 2025
Radiotherapy Deserves the Spotlight: The First World Radiotherapy Awareness DayPat Price, Sandra Lynne Turner, Katie Wakeham, et al.
BJU International|November 6, 2010
Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy: an increasing but under-recognised problemRuth Langley, Pat Price, Philip Pollock, et al.
The Lancet. Oncology|December 17, 2022
UK cancer care: a watershed moment and the need for urgent interventionPat Price, Richard Sullivan, Amar Ahmed, et al.
Biochimica Et Biophysica Acta|December 14, 2004
Measuring tumor pharmacodynamic response using PET proliferation probes: the case for 2-[(11)C]-thymidinePaula Wells, Catharine West, Terry Jones, et al.
The Lancet. Oncology|May 31, 2026
The UK's radiotherapy workforce shortage: a case for reformHoria Vulpe, Alison Tree, Pat Price, et al.
The Lancet. Oncology|August 23, 2024
The UK needs to be a leader, not a lagger, in the global cancer effortMark Lawler, Ajay Aggarwal, Julie Gralow, et al.
The Lancet. Oncology|November 9, 2025
A deliverable national cancer control plan for the UK: lessons from abroad and the need for discipline at homeMark Lawler, Cary Adams, Eduardo Pisani, et al.
Pageof 6